Loading...

Summit Therapeutics Inc.

SMMTNASDAQ
HealthcareBiotechnology
$19.72
$0.16(0.82%)

Summit Therapeutics Inc. SMMT Peers

See (SMMT) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SMMT$19.72+0.82%14.5B-58.00-$0.34N/A
VRTX$443.82-0.46%114B-115.88-$3.83N/A
REGN$483.07-0.38%51.3B12.27$39.36+0.37%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$307.89+0.85%40.1B-146.61-$2.10N/A
ARGX$580.30+1.18%35.4B35.43$16.38N/A
BNTX$110.15-0.90%26.5B-30.43-$3.62N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
RPRX$33.76+0.96%19B13.78$2.45+2.56%
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

SMMT vs VRTX Comparison

SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMMT stands at 14.5B. In comparison, VRTX has a market cap of 114B. Regarding current trading prices, SMMT is priced at $19.72, while VRTX trades at $443.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMMT currently has a P/E ratio of -58.00, whereas VRTX's P/E ratio is -115.88. In terms of profitability, SMMT's ROE is -0.70%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, SMMT is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.

Stock Price Comparison

Loading...

Frequently Asked Questions